Uridine is protective in a murine model of bronchial asthma Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009
Murine models of asthma Source: Eur Respir J 2003; 22: 374-382 Year: 2003
Effect of choline chloride in allergen-induced mouse model of airway inflammation Source: Eur Respir J 2007; 30: 662-671 Year: 2007
Effects of oral tolerance on neuronal nitric oxidase synthase expression on bronchial epithelial cells in a model of chronic pulmonary inflammation Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007
Effect of thrombin inhalation in a murine model of bronchial asthma Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
Effect of 1,25(OH)2 D3 on the airway inflammation in asthmatic rat model Source: Eur Respir J 2005; 26: Suppl. 49, 580s Year: 2005
Role of CD163 in human fatal asthma and murine asthma model. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018
Influence of acid sphingomyelinase deficiency in a murine model of allergen-induced asthma Source: Annual Congress 2011 - Animal models of airway inflammation Year: 2011
Effects of exogenous uridine in a sephadex-induced lung inflammation model in rats Source: Eur Respir J 2005; 26: Suppl. 49, 215s Year: 2005
Effects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation Year: 2008
Modulation of chronic airway inflammation in guinea pigs by oral tolerance: effects in lung mechanics, cellular infiltration and nitric oxide production Source: Eur Respir J 2002; 20: Suppl. 38, 382s Year: 2002
Cellular approach of salbutamol effects on chronic lung inflammation induced by OVA in murine model Source: Eur Respir J 2004; 24: Suppl. 48, 127s Year: 2004
Inhaled formulation of angiotensin-(1-7) produces lung protective effects in a model of chronic asthma. Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018
Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation Source: Eur Respir Rev 2015; 24: 204-215 Year: 2015
Combined effects of type 2 inflammation and lung function on exhaled nitric oxide ability to reflect asthma control Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019
Differential assessment of airway inflammation and anti-inflammatory treatment in asthma by measurements of exhaled nitric oxide (NO) derived from peripheral versus central airways Source: Eur Respir J 2003; 22: Suppl. 45, 449s Year: 2003
MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 20s Year: 2001
The impact of obesity on airway and lung parenchyma remodelling in a murine model of chronic allergic asthma Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
Opioid-neurotensin hybrid influences pulmonary inflammatory process in murine model of non-atopic asthma. Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017
Effects of ethyl pyruvate in a murine model of lipopolysaccharide-induced acute lung injury Source: Eur Respir J 2005; 26: Suppl. 49, 559s Year: 2005